Capital expenditure increased 92.5%
Capital expenditure changed +92.5% from the comparable as-filed period.
$53.0M→$102.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NTAP financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities increased 28.0%
Current liabilities changed +28.0% from the comparable as-filed period.
$3.6B→$4.6B3 prior comparisons
Trade receivables increased 22.7%
Trade receivables changed +22.7% from the comparable as-filed period.
$787.0M→$966.0M3 prior comparisons
Capex / revenue moved 164 bp higher
Capex / revenue changed +164 basis points from the comparable as-filed period.
3.40%→5.04%2 prior comparisons
Debt / equity moved 8845 bp lower
Debt / equity changed -8845 basis points from the comparable as-filed period.
254.87%→166.42%2 prior comparisons
Debt / revenue moved 3653 bp lower
Debt / revenue changed -3653 basis points from the comparable as-filed period.
159.40%→122.86%2 prior comparisons
Cash / debt moved 2068 bp lower
Cash / debt changed -2068 basis points from the comparable as-filed period.
83.90%→63.22%3 prior comparisons
Current assets increased 21.0%
Current assets changed +21.0% from the comparable as-filed period.
$4.7B→$5.7B3 prior comparisons
Debt / assets moved 296 bp lower
Debt / assets changed -296 basis points from the comparable as-filed period.
25.67%→22.71%3 prior comparisons
Research & development increased 13.2%
Research & development changed +13.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$242.0M→$274.0M2 prior comparisons
Receivables / revenue moved 278 bp lower
Receivables / revenue changed -278 basis points from the comparable as-filed period.
50.48%→47.70%2 prior comparisons
Free-cash-flow margin moved 1997 bp lower
Free-cash-flow margin changed -1997 basis points from the comparable as-filed period.
39.77%→19.80%2 prior comparisons
Operating cash-flow margin moved 1833 bp lower
Operating cash-flow margin changed -1833 basis points from the comparable as-filed period.
43.17%→24.84%2 prior comparisons
Operating cash flow / net income decreased 53.6%
Operating cash flow / net income changed -53.6% from the comparable as-filed period.
2.89→1.342 prior comparisons
Working capital / assets moved 147 bp lower
Working capital / assets changed -147 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
11.55%→10.08%3 prior comparisons
R&D / revenue moved 199 bp lower
R&D / revenue changed -199 basis points from the comparable as-filed period.
15.52%→13.53%2 prior comparisons
Gross margin moved 36 bp lower
Gross margin changed -36 basis points from the comparable as-filed period.
70.43%→70.07%2 prior comparisons
Total assets increased 13.2%
Total assets changed +13.2% from the comparable as-filed period.
$9.7B→$11.0B3 prior comparisons
Current long-term debt changed across a zero base
Current long-term debt changed from 0 to 550000000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$550.0M3 prior comparisons
Shares outstanding decreased 1.6%
Shares outstanding changed -1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
199,618,386→196,419,0058 prior comparisons
Stock-based compensation increased 18.1%
Stock-based compensation changed +18.1% from the comparable as-filed period.
$83.0M→$98.0M2 prior comparisons
Current ratio decreased 5.4%
Current ratio changed -5.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1.31→1.243 prior comparisons
SBC / revenue moved 48 bp lower
SBC / revenue changed -48 basis points from the comparable as-filed period.
5.32%→4.84%2 prior comparisons
Working capital decreased 1.3%
Working capital changed -1.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$1.1B→$1.1B3 prior comparisons
Reported total debt increased 0.1%
Reported total debt changed +0.1% from the comparable as-filed period.
$2.5B→$2.5B3 prior comparisons
Gross debt increased 0.1%
Gross debt changed +0.1% from the comparable as-filed period.
$2.5B→$2.5B3 prior comparisons
Inventory decreased 59.3%
Inventory changed -59.3% from the comparable as-filed period.
$268.0M→$109.0M2 prior comparisons
Gross margin moved 80 bp higher
Gross margin changed +80 basis points from the comparable as-filed period.
69.77%→70.58%1 prior comparisons
Net income increased 11.7%
Net income changed +11.7% from the comparable as-filed period.
$299.0M→$334.0M1 prior comparisons
Revenue increased 4.4%
Revenue changed +4.4% from the comparable as-filed period.
$1.6B→$1.7B1 prior comparisons
Cash & equivalents increased 7.8%
Cash & equivalents changed +7.8% from the comparable as-filed period.
$1.5B→$1.6B0 prior comparisons
SBC / revenue moved 61 bp lower
SBC / revenue changed -61 basis points from the comparable as-filed period.
6.28%→5.66%1 prior comparisons
Gross profit increased 5.6%
Gross profit changed +5.6% from the comparable as-filed period.
$1.1B→$1.2B1 prior comparisons
Research & development decreased 4.0%
Research & development changed -4.0% from the comparable as-filed period.
$247.0M→$237.0M1 prior comparisons
Stock-based compensation decreased 5.8%
Stock-based compensation changed -5.8% from the comparable as-filed period.
$103.0M→$97.0M1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.